Diampa 25 mg Tablet is an oral medication produced by Renata Limited in Bangladesh. Its active ingredient is Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor. Empagliflozin works by preventing glucose reabsorption in the kidneys, leading to increased glucose excretion in urine and thereby lowering blood sugar levels in patients with type 2 diabetes mellitus.